Latest Insights
Latest News
Catalyst, in collaboration with the Emily Whitehead Foundation, publishes Amplifying the Voice of CAR T-Cell Therapy Patients and Caregivers
Understanding the patient experience with CAR-T long-term follow-up (LTFU) is essential for building a sustainable model. Catalyst Healthcare Consulting, in partnership with the Emily Whitehead Foundation, surveyed nearly 100 patients and caregivers to capture their [...]
Cell & Gene Therapy is making swift progress, and Catalyst is keeping pace.
Scientific innovation in Cell & Gene Therapy (C>) is advancing rapidly, sparking hope for patients with rare diseases, cancer, and other debilitating conditions. The key is knowing where the advances may come from. To stay [...]
Califf: FDA will be a ‘more activist’ agency
Regulatory Focus - Aug. 24, 2023 Note: This article describes an interview co-moderated by Catalyst CEO Nancy Myers, along with Tom Kraus, VP- Government Relations, American Society for Health-System Pharmacists. The webinar interview was sponsored by [...]
Telework helps FDA compete for scientists. What if it’s no longer an option?
STAT+ May 11, 2023 Catalyst CEO and Founder Nancy Bradish Myers provided her perspective on FDA hybrid/telework policies and the impact of any potential changes in the future. With over 2,000 vacancies at the agency, [...]
Latest Blog Posts and Op Eds
Catalyst advances women’s health in new LinkedIn article
On Tuesday, Catalyst's Taryn Serman and Nancy Myers, together with industry leaders, published the following article regarding women's health on LinkedIn. A Case for Going Beyond Just Talking About Advancing Women's Health: Let's Take Action! [...]
The Catalyst Team shows support on Rare Disease Day
Being rare is often a blessing: a rare gem stands out from a pile of stones, a rare talent can garner prestige and success, and a rare personality can make for an influential leader or [...]
The launch of a patient-focused nonprofit: Catalyst Healthcare Consulting lends a hand
Two integral parts of Catalyst’s corporate mission are to 1) surf ahead of regulatory trends and anticipate environmental needs and 2) be good and do good. In the spirit of these objectives, we wanted to [...]
FDA Office of the Ombudsman: Focusing on Communication and Ensuring All Voices Are Heard
During an interview with the Alliance for a Stronger FDA on Aug. 30, 2023, Laurie Lenkel, JD, Director, FDA Office of the Ombudsman, provided an overview of the functions of the office, how it interacts [...]